Developer of synthetic biology platform designed to use data science to search for genomes for small molecule inhibitors of selected target proteins. The company's platform uses genomics, synthetic biology, and automation to discover evolutionarily refined molecules and their protein targets directly from fungal genomes for identifying medicines encoded in the global metagenome, enabling researchers to find a way to develop new medicines to improve the lives of the patients.